tradingkey.logo
tradingkey.logo
Search

ACADIA Pharmaceuticals Inc

ACAD
Add to Watchlist
29.500USD
+0.460+1.58%
Close 08-20 16:00ET
5.08BMarket Cap
13.23P/E TTM

ACADIA Pharmaceuticals Inc's Company Valuation

Currency: USD Updated: 2026-08-20
Previous score
7.92
Change
-1.42
The current valuation score of ACADIA Pharmaceuticals Inc is 6.50, ranking 312 out of 390 in the Biotechnology & Medical Research industry. Its current P/E ratio is 13.02, which is 693.64% below the recent high of 103.35 and 16701.56% above the recent low of -2161.97.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.